LIAISON® XL MUREX Anti-HDV

The accurate, easy, fast assay for HDV diagnosis from DiaSorin

The LIAISON® XL MUREX Anti-HDV assay is the first fully automated chemiluminescent immunoassay (CLIA) available on the market for the qualitative determination of antibodies to Hepatitis D Virus (Anti-HDV).

The assay is intended as an aid in the diagnosis of HDV infection in individuals with or without symptoms of hepatitis. It is also intended as a screening test for organ, tissue and cells post-mortem donors.
The assay has to be performed on the LIAISON® Analyzer family.

Key performances

Safety

Safety

Excellent diagnostic sensitivity (100%)

Accurate recognition of HDV-infected persons, optimize patients management

Efficiency

Efficiency

High specificity in samples from clinical routine and pregnancy testing (99.35%)

Time and cost savings due to less supplemental testing

Accuracy

Accuracy

High performances also on specimens collected post-mortem (non-heart beating)

Safety improvement

New LIAISON® XL MUREX Anti-HDV

  • high performances to assure reliable laboratory results
  • validation on cadaveric specimen to be compliance with regulations for organ, tissue and cells donors
  • total automation to guarantee easy and fast HDV diagnosis
  • one platform with the wides hepatitis diagnostic menu to optimize the workflow efficiency

LIAISON® XL MUREX Anti-HDV technical flyer

DOWNLOAD PDF